Endocardial fibroelastosis

From WikiMD's WELLNESSPEDIA


Endocardial fibroelastosis
Synonyms EFE
Pronounce N/A
Specialty N/A
Symptoms Heart failure, dyspnea, cyanosis, tachycardia
Complications Heart failure, arrhythmia
Onset Usually in infancy
Duration Chronic
Types N/A
Causes Often unknown, can be associated with viral infection or genetic disorder
Risks Congenital heart defect, family history
Diagnosis Echocardiography, chest X-ray, MRI
Differential diagnosis Dilated cardiomyopathy, restrictive cardiomyopathy
Prevention N/A
Treatment Diuretics, ACE inhibitors, beta blockers, heart transplant
Medication N/A
Prognosis Variable, often poor without treatment
Frequency Rare
Deaths N/A


Endocardial Fibroelastosis is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications.

Causes[edit]

The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications.

Symptoms[edit]

Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include:

  • Shortness of breath
  • Fatigue
  • Rapid heartbeat
  • Swelling in the legs, ankles, and feet

Diagnosis[edit]

Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an Echocardiogram, Electrocardiogram, and Cardiac MRI.

Treatment[edit]

Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a Heart transplant may be necessary.

Prognosis[edit]

The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.